ICICI Bank Limited Common Stock vs ImmunityBio Inc. Common Stock — how do they compare? ICICI Bank Limited Common Stock trades at $28 (market cap $100.09B), while ImmunityBio Inc. Common Stock trades at $9.98 (market cap $10.51B). The key difference: ICICI Bank Limited Common Stock is far larger — about 9.5× ImmunityBio Inc. Common Stock's market cap, and ICICI Bank Limited Common Stock pays a 0.9% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ICICI Bank Limited Common Stock for 0 Days and ImmunityBio Inc. Common Stock for 0 Days on average.
| IBN | IBRX | |
|---|---|---|
Market Cap | $100.09B | $10.51B |
Volume | 5,088,983 | 10,445,785 |
Sector | Financials | Health |
52-Week High | $32.94 | $11.55 |
52-Week Low | $25.20 | $1.98 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.03T | $10.97B |
Dividend Yield | 0.9% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
ICICI Bank is an Indian financial services company providing banking, lending, cards, insurance, and investment products. It serves retail, business, and corporate customers.
Read more on IBN →ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →